The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid Hemorrhage
2 other identifiers
interventional
25
1 country
1
Brief Summary
The purpose of the study is to see that in addition to existing therapy, how well an additional procedure named spinal cord stimulation might reduce blood vessel spasm from aneurysm rupture.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 6, 2024
CompletedFirst Posted
Study publicly available on registry
June 5, 2024
CompletedStudy Start
First participant enrolled
July 31, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2027
Study Completion
Last participant's last visit for all outcomes
July 31, 2027
July 10, 2025
July 1, 2025
8 months
May 6, 2024
July 9, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Pre-Cerebrovascular response - Velocity
Pre-SCS measures of cerebral blood flow. Subjects will serve as their own internal control (on vs off stimulation) and be grouped collectively to enable more robust statistical analysis. To study the effect of SCS on cerebrovascular tone longitudinally over the course of the vasospasm window, mixed model statistics will be applied.
Day 1 - Day 14
Pre-Cerebrovascular response - Resistance
Pre-SCS measures of cerebral blood flow. Subjects will serve as their own internal control (on vs off stimulation) and be grouped collectively to enable more robust statistical analysis. To study the effect of SCS on cerebrovascular tone longitudinally over the course of the vasospasm window, mixed model statistics will be applied.
Day 1 - Day 14
Pre-Cerebrovascular response - Lindegaard ratio
Pre-SCS measures of cerebral blood flow. Subjects will serve as their own internal control (on vs off stimulation) and be grouped collectively to enable more robust statistical analysis. To study the effect of SCS on cerebrovascular tone longitudinally over the course of the vasospasm window, mixed model statistics will be applied.
Day 1 - Day 14
Post-Cerebrovascular response - Velocity
Post SCS measures of cerebral blood flow. Subjects will serve as their own internal control (on vs off stimulation) and be grouped collectively to enable more robust statistical analysis. To study the effect of SCS on cerebrovascular tone longitudinally over the course of the vasospasm window, mixed model statistics will be applied.
Day 1 - Day 14
Post-Cerebrovascular response - Resistance
Post SCS measures of cerebral blood flow. Subjects will serve as their own internal control (on vs off stimulation) and be grouped collectively to enable more robust statistical analysis. To study the effect of SCS on cerebrovascular tone longitudinally over the course of the vasospasm window, mixed model statistics will be applied.
Day 1 - Day 14
Post-Cerebrovascular response - Lindegaard ratio
Post SCS measures of cerebral blood flow. Subjects will serve as their own internal control (on vs off stimulation) and be grouped collectively to enable more robust statistical analysis. To study the effect of SCS on cerebrovascular tone longitudinally over the course of the vasospasm window, mixed model statistics will be applied.
Day 1 - Day 14
Transcranial Doppler (TCD) velocities of cerebral arteries
Daily transcranial Doppler studies will be performed to obtain quantitative data on cerebrovascular response during the critical 14-day vasospasm window.
Day 1 - Day 14
Secondary Outcomes (1)
Overall Survival
Through study completion, approximately 24 months
Study Arms (2)
Spinal Cord Stimulation
EXPERIMENTALParticipants randomized to receive temporary electrode inserted through the skin into the epidural space of participants upper back/lower neck.
Sham Comparator
SHAM COMPARATORParticipants randomized to not receive temporary electrode.
Interventions
The electrode is placed into the epidural space using standard epidural placement techniques with paramedian approach. The initial electrode settings have been adopted from prior studies. Should any significant discomfort be elicited from the stimulation, first the amplitude will be decreased to an acceptable level. If an acceptable level of stimulation is unable to be found, the stimulation will be discontinued.
Eligibility Criteria
You may qualify if:
- Provision of signed and dated informed consent form
- Stated willingness to comply with all study procedures and availability for the duration of the study
- Diagnosed with Fisher grade 3 or 4 aneurysmal subarachnoid hemorrhage (1)
- Ability to undergo endovascular treatment of aneurysmal subarachnoid hemorrhage
- For females of reproductive potential: Negative pregnancy test at time of treatment
- Plan to undergo standard of care and follow-up
You may not qualify if:
- Medically unfit to undergo endovascular treatment (e.g., Hunt Hess grade 5)
- Does not provide consent for the procedure.
- Posterior circulation aneurysmal subarachnoid hemorrhage.
- Initial aneurysm treatment after post bleed day 1
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Alabama at Birmingham
Birmingham, Alabama, 35233, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jesse Jones, MD
University of Alabama at Birmingham
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
May 6, 2024
First Posted
June 5, 2024
Study Start (Estimated)
July 31, 2026
Primary Completion (Estimated)
March 31, 2027
Study Completion (Estimated)
July 31, 2027
Last Updated
July 10, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share